Enhanced antitumor activity of P450 prodrug-based gene therapy using the low Km cyclophosphamide 4-hydroxylase P450 2B11.

Source:http://linkedlifedata.com/resource/pubmed/id/16546968

Download in:

View as

General Info

PMID
16546968